Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
RMTIthis companyRockwell Medical, Inc.	$7.68	-5.56×	0.81×	0.43×	-15.9×	-661.9%	16.9%	-6.8%	-7.7%	-14.4%	-9.5%	-4.0%	0.34×	-0.88×	-4.17×	3.98×	0.0%	5	-7.74	2	C
APUSApimeds Pharmaceuticals US, Inc	$2.69	-2.98×	0.12×	0×	-4.2×	-321.0%	0.0%	0.0%	0.0%	-3.9%	-7.4%	-50.3%	0.05×	-1.07×	-42.09×	1.31×	0.0%	1	-2.08	2	C+
CPIXCumberland Pharmaceuticals Inc.	$5.45	-20.95×	2.39×	1.34×	19.7×	-102.6%	85.0%	-6.3%	-6.4%	-11.4%	-6.9%	8.1%	0.41×	-0.43×	-5.63×	1.01×	0.0%	3	0.04	2	C
LIMNLiminatus Pharma, Inc. Class A Common Stock	$2.75	-1.42×	-1.48×	0×	-1.56×	-235.7%	0.0%	0.0%	0.0%	104.0%	35.6%	-68.9%	-0.15×	-0.11×	-13.75×	0.05×	0.0%	2	-28.31	1	D+
NMTCNeuroOne Medical Technologies Corporation	$0.92	-9.87×	5.04×	2.95×	-9.76×	-18014.5%	67.3%	-34.9%	-29.8%	-51.0%	-49.1%	-8.2%	0.04×	2.09×	-12.65×	4.44×	0.0%	3	-18.47	1	C-
STRRStar Equity Holdings, Inc.	$9.47	-5.41×	0.55×	0.21×	-28.29×	-2243.4%	45.7%	-2.1%	-3.4%	-9.0%	-4.0%	-24.9%	0.4×	-8.06×	0×	2.1×	2.1%	1	-3.23	2	C+
Peer median	—	-5.41×	0.55×	0.21×	-4.2×	-321.0%	45.7%	-2.1%	-3.4%	-9.0%	-6.9%	-24.9%	0.05×	-0.43×	-12.65×	1.31×	0.0%	2	-3.23	2	—